Dr Jiwon Oh looks forward to hearing updates on major clinical trials and long-term studies of new and emerging MS treatments at ECTRIMS 2025.

A North Hampshire woman is marking ten years since being diagnosed with multiple sclerosis (MS) by leading a 47-mile charity ...

Columnist Ben Hofmeister worries about his MS cognitive symptoms worsening and wonders if he'll even be aware of the changes.

AlterEgo's neural-interface device is non-invasive and is being tested in people with multiple sclerosis and amyotrophic ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical-stage biopharmaceutical company pioneering differentiated therapies for the treatment of neuroscience, inflammation ...

Those who prescribe larger amounts of MS drugs were more likely to have received payments, and those who got payments were ...

For more than 60 years, the medical community has been refining the diagnosis of multiple sclerosis. The diagnosis of multiple sclerosis typically involves the detection of demyelinating episodes that ...

A Monash University-led study published in JAMA Network Open was the first to examine the impact of pregnancy on multiple sclerosis (MS) relapse ...

SHREVEPORT, La. - A cutting-edge clinical trial is now underway in Shreveport, and local patients with Multiple Sclerosis are ...

Columnist Desiree Lama struggles to effectively manage stress, but given her multiple sclerosis, learning to do so is vital, ...

Dr Devon Conway describes how the upcoming conference is expected to provide important new data on the safety and real-world ...

Emotional challenges are common when living with a progressive condition, such as SPMS, though often overlooked. These strategies can help you cope.